Starting at 0800, Friday, December 8th, 2023, instrumentation in the core clinical laboratory will be undergoing maintenance. This will delay the resulting of the following assays between 0800 – 1300:
Alpha 1 Antitrypsin [LAB927]
Amikacin drug level [LAB555]
Beta 2 Microglobulin [LAB49]
Bile Acids, Total [LAB2713]
Buprenorphine, Urine Screen [LAB8779]
Buprenorphine Compliance Screen with Reflex [LAB8780]
C3 Complement [LAB152]
C4 Complement [LAB151]
Carbamazepine drug level [LAB22]
Cardiac CRP [LAB150]
Ceruloplasmin [LAB582]
Cystatin C [LAB2967]
Ethylene glycol, rapid assay [LAB7453]
Everolimus drug level [LAB7456]
Haptoglobin [LAB89]
Homocysteine [LAB93]
IgA [LAB73]
IgG [LAB71]
IgM [LAB72]
Kappa/lambda quant free light chain ratio, blood [LAB7454]
Keppra (levetiracetam) drug level [LAB477]
Lamotrigine (Lamictal) drug level [LAB475]
Lidocaine drug level [LAB641]
Pentobarbital drug level [LAB656]
Phenobarbital drug level [LAB30]
Phenytoin free drug level [LAB32]
Phenytoin drug level [LAB31]
Rheumatoid factor [LAB206]
Theophylline drug level [LAB35]
Tobramycin drug level [LAB36]
Urine Neutrophil Gelatinase-Associated Lipocalin [LAB8693]
Valproic acid drug level [LAB25]
Questions should be directed to Anna Merrill, PhD (678-8400, anna-merrill@uiowa.edu) or Matthew Krasowski, MD, PhD (384-9380, matthew-krasowski@uiowa.edu).